Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Greenblatt RM, Han JH, Nachamkin I, Tolomeo P, Lautenbach E.

Infect Control Hosp Epidemiol. 2013 Jan;34(1):40-8. doi: 10.1086/668780. Epub 2012 Nov 21. Review.

2.

Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.

Usein CR, Tatu-Chiţoiu D, Nica M, Ciontea SA, Palade AM, Condei M, Damian M.

Roum Arch Microbiol Immunol. 2008 Jan-Jun;67(1-2):23-9.

PMID:
19284163
3.

Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.

Lautenbach E, Metlay JP, Weiner MG, Bilker WB, Tolomeo P, Mao X, Nachamkin I, Fishman NO.

Infect Control Hosp Epidemiol. 2009 Jan;30(1):18-24. doi: 10.1086/592703.

4.

Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns.

Takahashi A, Muratani T, Yasuda M, Takahashi S, Monden K, Ishikawa K, Kiyota H, Arakawa S, Matsumoto T, Shima H, Kurazono H, Yamamoto S.

J Clin Microbiol. 2009 Mar;47(3):791-5. doi: 10.1128/JCM.01740-08. Epub 2009 Jan 21.

5.

Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.

Han JH, Bilker WB, Nachamkin I, Tolomeo P, Mao X, Fishman NO, Lautenbach E.

Infect Control Hosp Epidemiol. 2013 Oct;34(10):1070-6. doi: 10.1086/673155. Epub 2013 Aug 23.

6.

Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coli.

Han JH, Nachamkin I, Tolomeo P, Mao X, Bilker WB, Lautenbach E.

J Infect Dis. 2012 Nov 15;206(10):1597-603. doi: 10.1093/infdis/jis567. Epub 2012 Sep 10.

7.
8.

The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.

Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I.

Clin Infect Dis. 2010 Aug 1;51(3):280-5. doi: 10.1086/653931.

9.

Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):361-9. doi: 10.1086/669865. Epub 2013 Feb 13.

10.

Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA.

JAMA. 1999 Feb 10;281(6):517-23.

PMID:
10022107
11.

Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital.

Yoo JS, Kim HM, Koo HS, Yang JW, Yoo JI, Kim HS, Park HK, Lee YS.

J Antimicrob Chemother. 2013 Sep;68(9):2170-2. doi: 10.1093/jac/dkt126. Epub 2013 May 21. No abstract available.

12.

Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.

Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, Pascual A.

Clin Infect Dis. 2006 Jan 1;42(1):37-45. Epub 2005 Nov 29.

13.

[Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].

Kırca Yılmaz S, Acuner IC, Strommenger B, Bek Y, Witte W.

Mikrobiyol Bul. 2014 Jan;48(1):14-27. Turkish.

14.
15.

Prevalence and genetic relatedness of antimicrobial-resistant Escherichia coli isolated from animals, foods and humans in Iceland.

Thorsteinsdottir TR, Haraldsson G, Fridriksdottir V, Kristinsson KG, Gunnarsson E.

Zoonoses Public Health. 2010 May;57(3):189-96. doi: 10.1111/j.1863-2378.2009.01256.x. Epub 2009 Nov 13.

PMID:
19912612
16.

A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.

Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S, Balan VK, Zirnstein G, Cieslak PR, Angulo FJ.

N Engl J Med. 2001 May 24;344(21):1572-9.

17.

Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.

Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A.

J Infect Dis. 2002 Dec 15;186(12):1852-6. Epub 2002 Nov 22. Erratum in: J Infect Dis. 2003 Mar 15;187(6):1025..

18.

Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients.

Hu YY, Cai JC, Zhou HW, Chi D, Zhang XF, Chen WL, Zhang R, Chen GX.

Appl Environ Microbiol. 2013 Oct;79(19):5988-96. doi: 10.1128/AEM.01740-13. Epub 2013 Jul 26.

19.

Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants.

Yang J, Luo Y, Li J, Ma Y, Hu C, Jin S, Ye L, Cui S.

J Antimicrob Chemother. 2010 Mar;65(3):453-9. doi: 10.1093/jac/dkp478. Epub 2010 Jan 7.

20.

Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens.

Karlowsky JA, Kasloff S, Nichol KA, Hoban DJ, Zhanel GG.

Diagn Microbiol Infect Dis. 2007 Jul;58(3):283-7. Epub 2007 Mar 26.

PMID:
17376632
Items per page

Supplemental Content

Write to the Help Desk